Equities
  • Price (GBX)318.55
  • Today's Change-0.95 / -0.30%
  • Shares traded1.93k
  • 1 Year change-35.70%
  • Beta0.8642
Data delayed at least 15 minutes, as of Feb 20 2019 16:27 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Scapa Group plc is a United Kingdom-based global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets. The Company has a global footprint, with production sites in Asia, Europe and the United States. The Company conducts the activities through two distinct and separate businesses: Healthcare and Industrial business units. The Company’s subsidiary Scapa Healthcare is a outsource partner in the advanced wound care, consumer wellness, medical device fixation and drug delivery markets. Scapa Industrial operates across a diverse range of market segments throughout Europe, North America and Asia, through the two business models of engineered products and commercial products.

  • Revenue in GBP (TTM)286.60m
  • Net income in GBP18.60m
  • Incorporated1964
  • Employees1.31k
  • Location
    Scapa Group PLCManchester RoadASHTON-UNDER-LYNE OL7 0EDUnited KingdomGBR
  • Phone+44 16 1301 7400
  • Fax+44 16 1301 7591
  • Websitehttp://www.scapa.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SCPA:LSE since
announced
Transaction
value
BioMed Laboratories LLCDeal completed26 Mar 201826 Mar 2018Deal completed-33.65%32.00m
Data delayed at least 20 minutes, as of Feb 20 2019 16:37 GMT.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.